Jump to main content.


Computational Toxicology Seminar Series

You will need Adobe Acrobat Reader, available as a free download, to view the Adobe PDF files on this page. See EPA's PDF page to learn more about PDF, and for a link to the free Acrobat Reader.

Next Seminar

On Wednesday, October 8, 2008, at 1:30 PM ET, the next in a series of monthly Info on Informatics seminars will feature Dr. Frank J. Gonzalez.  Dr. Gonzalez will be speaking on From Xenobiotic Metabolism to Xenobiotic Metabolomics .

   When: Wednesday, October 8, 2008, 1:30 PM
   Location: RTP Room C114
   Speaker: Dr. Frank J. Gonzalez
National Cancer Institute
laboratory of Metabolism
National Institutes of Health
Bethesda, MD
   Call In Line: 1-866-299-3188 conference code is 9195411504#
   Abstract: Metabolomics is the study of changes in the population of small molecules or metabolomes, in cells, tissues and biological fluids such as serum and urine. Metabolomics, using 1H-NMR, has gain prominence and been embraced by the pharmaceutical industry as a means to determine the potential toxic effects of drugs. For example, a chemical is administered to rodents and urine and serum examined for the presence of metabolites that reflect organ-specific toxicities. Mass spectrometry coupled with liquid or gas chromatography, is gaining increased use for metabolomics due to lower costs and more widespread equipment availability as compared to NMR. In particular, ultra performance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC- TOFMS) yields high-resolution separation and exact mass determination of compounds in biological materials. The UPLC-TOFMS data are deconvoluted by various multivariate data analysis software such as principal components analysis (PCA) and Random Forrest to find differences between samples. To study xenobiotic metabolism and toxicity, compounds are administered to mice and serum and urine examined by PCA for the presence of the parent compound and its metabolites that are not found in untreated mice. Metabolites derived from the drug as well as endogenous metabolites that reflect the drugs biological activity or toxicity can be resolved. Metabolomics is also being used to search for biomarkers for various diseases that involve chemical insults such as cancer and metabolic diseases. This can be accomplished by use of cancer bioassays in mice and directly by studying human cancer patients and controls. These biomarkers can developed for use in early cancer detection and for determining the efficacy/toxicity of cancer therapy.

For further information, please contact David Dix, 919-541-2701

Background information about the STAR Environmental Bioinformatic Centers

In November 2005, EPA announced an award of $9 million to establish two cutting-edge environmental bioinformatics research centers at the University of North Carolina (UNC) at Chapel Hill and the University of Medicine and Dentistry of New Jersey (UMDNJ). The centers represent a major component of EPA's computational toxicology program that is using computer models to study the relationship between environmental contaminants and their potential adverse effects. The Research Center for Environmental Bioinformatics and Computational Toxicology at the University of Medicine & Dentistry of New Jersey (UMDNJ) in Piscataway brings together a team of computational scientists with diverse backgrounds in bioinformatics, chemistry, modeling, and environmental studies from UMDNJ, Rutgers, and Princeton Universities, and the U.S. Food and Drug Administration's Center for Toxicoinformatics. The Carolina Environmental Bioinformatics Research Center at the University of North Carolina, Chapel Hill, brings together many researchers and disciplines, combining expertise in biostatistics, computational biology, chemistry, and computer science to advance the field of computational toxicology.

In order to best interface the activities of the Environmental Bioinformatic Centers with the research being conducted within ORD, an information program is being established. Each month, one of Centers will present an overview of the activities covered under one of their major projects. These sessions will be open to all EPA staff who are interested in helping the Centers achieve their long-term objectives. While the number of interactions that can be developed are limited by available resources, it is anticipated that these forums will facilitate the development of collaborative research projects. After the initial round of informational briefing, this program will evolve into a forum for presenting advances in environmental bioinformatics that will assist ORD in supporting the mission of the EPA of protecting human health and the environment.

If you have any questions about the seminar series, please contact Richard Judson at judson.richard@epa.gov. For information on the STAR centers, please contact NCER's project officer, Deborah Segal at segal.deborah@epa.gov.

Schedule
Computational Toxicology Seminar Series
"Info on Informatics"

Date Speaker Seminar Title Files
Nov 12th, 2008 Douglas Lauffenberger    
Oct 8th, 2008 Frank Gonzalez From Xenobiotic Metabolism to Xenobiotic Metabolomics Abstract (1 pp, 10 KB)
Sep 10th, 2008 Alex Tropsha A combined use of in vitro screening and cheminformatics approaches improves the accuracy of in vivo toxicity models Presentation (61 pp, 2.59 MB)
June 23, 2008 Richard T. Miller Hepatotoxicity Testing; Predictive Strengths and Weaknesses Presentation (42 pp, 1.5 MB)
May 14th, 2008 Ivan Russyn Genome-level analysis of genetic regulation of liver gene expression networks  
Apr 9th, 2008 Alison Motsinger Grammatical Evolution Neural Networks for Genetic Epidemiology Presentation (42 pp, 510 KB)
Mar 12th, 2008 Ioannis P. Androulakis From Data to Models: Systems biology methods and potential applications to toxicoinformatics Presentation (32 pp, 4.1 MB)
Feb 13th, 2008 Rusty Thomas Dose Response Modeling of Genomic Data and Application to Human Risk Assessment
Jan 23rd, 2008 George K. Michalopoulos Liver Regeneration: Initiation and Termination Signals Presentation
Nov 14th, 2007 Gavin Maxwell,
Cameron MacKay
Mathematical modelling of skin sensitization: Guiding in vitro assay development for use in novel risk assessment methods.

Mathematical modelling of skin sensitization: Practicalities of the modelling process
Abstract (2 pp, 82 KB)
Morning Presentation (37 pp, 1.0 MB)
Afternoon Presentation (59 pp, 2.3 MB)
May 9th, 2007 Fred A. Wright and Zhen Li Discovering Relevant Pathways in Microarray Experiments - A Tutorial on Honest Testing Methods Presentation (44 pp, 1.1 MB)
Apr 11th, 2007 I.P. Androulakis Incorporating Toxicogenomic Data and Approaches in Risk Assessment: Case Study - Phthalate Esters Presentation (23 pp, 806 kB)
Mar 14th, 2007 Peter A. DiMaggio Jr. and Christodoulos A. Floudas Optimization Tools for in silico Proteomics Presentation (41 pp, 2.6 MB)
Feb 14th, 2007 David Stotts Subspace Clustering for Mining High Dimensional Data/Federated Scientific Models Presentation (32 pp, 1.4 MB)
Dec 13th, 2006 William Welsh Cheminformatics Tools for Toxicant Identification and Characterization Presentation (32 pp, 4.8 MB)
Nov 08th, 2006 Alexander Tropsha, Hao Zhu, Kun Wang Challenges in Predictive QSTR Modeling Presentation (44 pp, 928 KB)
Oct 11th, 2006 Xiao-Jiang Feng, Genyuan Li, Herschel Rabitz A Closed-loop Identification Protocol (CLIP) for Nonlinear Biological Networks Presentation (27 pp, 1.2 MB)
Sept 13th, 2006 Ivan Rusyn Toxicogenetic Dimensions in Studies of the Mechanisms of Liver Injury: A Driving Biological Problem Presentation (15 pp, 981 KB)
June 14th, 2006 Panos Georgopoulos Computational Tools for the Source to Outcome Paradigm Presentation (52 pp, 6.4 MB)
Abstract (1 pp, 16 KB)
May 10th, 2006 Fred Wright, William Welsh, Panos Georgopoulos What's Ahead in the Information Series UNC Presentation (41 pp, 2.2 MB)
UMDNJ Presentation (53 pp, 4.6 MB)

Local Navigation


Jump to main content.